He's formed Vos BioTech and intends to retain as many of the plant's employees as possible. When Elanco announced in September last year that it ...
News
- Former employee buys out owners of animal vaccine plant
- Acceleron: 3Q Earnings Snapshot
The clinical stage biotech developing protein therapeutics for cancer and rare diseases posted revenue of $3.3 million in the period, which fell short of ...
- Amgen: 3Q Earnings Snapshot
The world's largest biotech drugmaker posted revenue of $5.9 billion in the period, also beating Street forecasts. Seven analysts surveyed by Zacks ...
- Rheonix Announces Launch of NGS OnePrep™ Automated DNA Extraction and Library ...
... workstation, at the Association of Molecular Pathology (AMP) Annual Meeting and Expo Nov.1-3 in San Antonio, Texas. ... INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS MEDICAL DEVICES GENERAL HEALTH.
- The CEO of This Biotech Company Focused on Rare Diseases Is a Patient Himself
Horizon Pharma is an industry leader in the biotechnology sector, focusing on research and development for rare and rheumatic diseases. Chairman ...